Today's Headlines: Hurricane Sally Slams the Florida Panhandle With Deluge of Rain

Trump Scorns His Own Scientists Over Virus Data
View in Browser | Add nytdirect@nytimes.com to your address book.

Thursday, September 17, 2020

Top News

Hurricane Sally Slams the Florida Panhandle With Deluge of Rain

Hurricane Sally Slams the Florida Panhandle With Deluge of Rain

By Richard Fausset, Rick Rojas and Nicholas Bogel-Burroughs

The sluggish storm veered east and intensified before making landfall near the Alabama and Florida state line. Residents and officials said they were not anticipating a direct hit.

Trump Scorns His Own Scientists Over Virus Data

Trump Scorns His Own Scientists Over Virus Data

By Peter Baker

A public scolding of the C.D.C. chief was only the latest but perhaps the starkest instance when the president has rejected not just the policy advice of his public health officials but the facts and information that they provided.

A Desperate Bid for Survival as Fire Closed In on an Oregon Mountain Town

A Desperate Bid for Survival as Fire Closed In on an Oregon Mountain Town

By Jack Healy and Mike Baker

After wildfires left them trapped on the shores of a reservoir near Detroit, Ore., dozens of people and nine firefighters mounted a last stand, hoping for a miracle.

For more top news, go to NYTimes.com »
ADVERTISEMENT

Editors' Picks

A Civil War Political Movement Reawakens — Complete With Capes

Style

A Civil War Political Movement Reawakens — Complete With Capes

By Matt Dellinger

In 1860, the Wide Awakes mobilized against slavery and for Abraham Lincoln. A new collective is tapping into their spirit today.

The Most Powerful Man in the World Thinks My Family Is 'Less Than'

Opinion

The Most Powerful Man in the World Thinks My Family Is 'Less Than'

By Jennifer Finney Boylan

The fight for equality isn't over, and can most definitely still be lost.

Today's Videos

'Scientific Breakthroughs Don't Care About Calendars,' Biden Says

Video Video: 'Scientific Breakthroughs Don't Care About Calendars,' Biden Says

By Reuters

The Democratic presidential nominee, Joseph R. Biden Jr., expressed concern that President Trump was trying to rush coronavirus vaccine approval for political gain.

Coronavirus Is the 'No. 1 Global Security Threat,' Head of U.N. Says

Video Video: Coronavirus Is the 'No. 1 Global Security Threat,' Head of U.N. Says

By Reuters

United Nations Secretary General António Guterres called the coronavirus pandemic the world's top security threat, and called for greater cooperation in controlling outbreaks and developing an affordable vaccine.

China-Backed Hackers Infiltrated Firms Across the Globe, U.S. Says

Video Video: China-Backed Hackers Infiltrated Firms Across the Globe, U.S. Says

By The Associated Press

The Justice Department charged five Chinese nationals with breaking into 100 firms and agencies to steal information, hijack networks and extort victims.

|
Get unlimited access to NYTimes.com and our NYTimes apps. Subscribe »
Copyright 2020 The New York Times Company
620 Eighth Avenue New York, NY 10018

Coronavirus Briefing: A potential treatment

A monoclonal antibody treatment was shown to lower levels of the virus in infected patients.
Coronavirus Briefing

September 16, 2020

An informed guide to the global outbreak, with the latest developments and expert advice about prevention and treatment.

(Was this email forwarded to you? Sign up here.)

The New York Times

A drugmaker reports positive results for a potential treatment

The pharmaceutical company Eli Lilly announced that a single infusion of its monoclonal antibody treatment was shown to drastically lower levels of the coronavirus in newly infected patients and lower the likelihood of requiring hospitalization.

It is the first potential treatment for patients with mild or moderate Covid-19. (The two other treatments that have proved helpful, the antiviral remdesivir and the steroid dexamethasone, are only for the seriously ill.)

Scientists used blood plasma from Covid-19 survivors, isolating and testing their antibodies to find the most powerful ones. They then manufactured vats of antibodies to make the drug. In a trial of more than 450 newly diagnosed Covid-19 patients, Eli Lilly said, only about 1.7 percent of those who received the drug ended up in the hospital, compared with 6 percent who were given a placebo — a 72 percent risk reduction. Those treated with the drug reportedly also had fewer symptoms, and the levels of virus in their bodies plummeted.

Other companies are also working on treatments with monoclonal antibodies, but they are difficult and expensive to make. A single dose could cost thousands of dollars. They offer only a temporary solution, with the antibodies lasting about a month.

But without a vaccine — the only way to elicit a lasting immune response — the treatment could give doctors another weapon in an arsenal with few options.

The study will eventually enroll 800 patients in the U.S. of all ages and risk categories, including people in nursing homes. Eli Lilly has already started manufacturing 10,000 doses in hopes that these interim results, which have not yet been peer reviewed, will bear out.

The company plans to discuss the state of the trial with the Food and Drug Administration, as well as the possibility of emergency use authorization to market the drug.

New York City finds a way to speed testing

After months of testing headaches and complaints about delays, New York City is getting a dedicated lab that will prioritize tests from city residents.

The new Pandemic Response Lab in Manhattan is run by a small robotics company, but the city played a significant role in its creation, officials said.

The hope is that the lab will cut wait times down to 24 to 48 hours, just as the city prepares for its most ambitious period of reopenings, with some in-person public school classes and indoor dining scheduled to begin this month.

New York City’s testing program is already one of the most ambitious in the country, swabbing more than 200,000 people a day, or more than 2 percent of all city residents. The lab will be able to process an additional 40,000 tests and will possibly include some from public school students and teachers.

In other New York news:

  • Facing a $9 billion, two-year revenue shortfall because of the coronavirus’s impact on the economy, Mayor Bill de Blasio announced that he was furloughing staff members at City Hall, himself included (the mayor intends to work during his furlough, for free).
  • The city changed its hybrid education model, which involves students physically attending school one to three days per week and learning remotely the rest of the time. Because of a staffing crunch, schools will no longer be required to provide daily live instruction to hybrid students when they are at home.
  • The Brooklyn Museum is breaking a taboo, putting 12 works up for auction to raise money for the care of its collection. The auction next month will include paintings by Cranach, Courbet and Corot.

Resurgences

  • The case count in India topped five million — less than a month after it hit three million.
  • Spain’s capital, Madrid, is preparing to impose “selective lockdowns” in areas where cases have risen significantly, an official warned. About a third of Spain’s new cases over the last week were in the city.
  • With Israel’s infection rates having spiraled to among the worst in the world, the Great Synagogue in Jerusalem will remain closed over the Jewish high holidays, for the first time in its history.

What else we’re following

What you’re doing

I am a preschool teacher in Los Angeles, so the theme for the Zooms this week has been fire safety. The kids all dressed up like firefighters and shared their toy fire trucks. I made a video visiting a fire station and interviewed the firefighter. He turned the lights on the truck and drove in and out of the station for us. Not as fun as touring the station, with all the mom escort volunteers who love firefighters too — but the kids really enjoyed it.

— Sylvia Rath, Los Angeles

Let us know how you’re dealing with the outbreak. Send us a response here, and we may feature it in an upcoming newsletter.

Email your thoughts to briefing@nytimes.com. Did a friend forward you the briefing? Sign up here.

Need help? Review our newsletter help page or contact us for assistance.

You received this email because you signed up for Coronavirus Briefing from The New York Times.

To stop receiving these emails, unsubscribe or manage your email preferences.

Subscribe to The Times

Connect with us on:

facebooktwitterinstagram

Change Your EmailPrivacy PolicyContact UsCalifornia Notices

The New York Times Company. 620 Eighth Avenue New York, NY 10018